ARID2 and hepatocellular carcinoma: Wnt signaling, telomere maintenance and cell cycle control were significantly altered by mutations in HCC [6], while chromatin remodelers e.g. ARID1A, ARID2 and BRD7 were also found to be mutated and de-regulated in HCC patients [6, 8].